Articles by Amir Ali, PharmD, BCOP

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease
ByAmir Ali, PharmD, BCOP,Amin Khudari, PharmD Candidate,Vincent Mendiola, MD,George Yaghmour, MD,Samantha Shi, PharmD, BCOP,Hien Tang, PharmD, BCOP,Harry Shamamian, PharmD, MBA, FACHE Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.

Substantial strides have been made in the management of Ph+ ALL.

Real-World Efficacy, Safety of Tixagevimab/Cilgavimab in Patients With Cancer After EUA Revision
ByAnn Tong, PharmD,Yijun Cai, PharmD Candidate,Samantha Shi, PharmD, BCOP,Hien Tang, PharmD, BCOP,Harry Shamamian, PharmD, MBA, FACHE,Amir Ali, PharmD, BCOP The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.

A retrospective analysis presents unique results for AML treatment.